POINT Biopharma Global Inc.: 25-NSE filed Dec 27, 2023

Form type

25-NSE

Filing date

Dec 27, 2023

Accession number

0001354457-23-001006

Filer

POINT Biopharma Global Inc. (CIK 1811764)